HRT Financial’s NuVasive, Inc. NUVA Stock Holding History

HRT Financial’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-18,329	Closed	-$757K	–	3579
2023 Q1	$757K	Buy	+18,329	New	+$784K	0.01%	1103
2022 Q4	–	Sell	-167,397	Closed	-$7.33M	–	3475
2022 Q3	$7.33M	Buy	+167,397	New	+$8.11M	0.08%	194
2022 Q1	–	Sell	-6,768	Closed	-$355K	–	4101
2021 Q4	$355K	Buy	+6,768	New	+$368K	﹤0.01%	2141
2021 Q3	–	Sell	-14,939	Closed	-$1.01M	–	3918
2021 Q2	$1.01M	Buy	+14,939	New	+$1.02M	0.01%	1080
2021 Q1	–	Sell	-11,637	Closed	-$655K	–	3296
2020 Q4	$655K	Buy	+11,637	New	+$572K	0.01%	884
2020 Q1	–	Sell	-2,950	Closed	-$228K	–	1481
2019 Q4	$228K	Buy	+2,950	New	+$208K	0.01%	884

Other funds holding NUVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

HRT Financial's NUVA Position: Q2 2023 in Review

HRT Financial sold out of NuVasive, Inc. (NUVA) in Q2 2023, closing a stake of 18,329 shares — an estimated $757K sold.

HRT Financial first reported a position in NUVA in Q4 2019 and held it in 6 quarters. The position peaked at $7.33M in Q3 2022. 228 funds tracked by Wall St. Rank hold NUVA as of Q2 2023.

HRT Financial reported no remaining NuVasive, Inc. position as of Q2 2023 after selling out during the quarter.
HRT Financial sold 18,329 NuVasive, Inc. shares in Q2 2023, an estimated $757K.
HRT Financial first reported a position in NuVasive, Inc. in Q4 2019 and held it in 6 quarters.
HRT Financial's NuVasive, Inc. position peaked at $7.33M in Q3 2022.
228 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q2 2023.

Based on HRT Financial's 13F filing for Q2 2023, filed 11 Aug 2023.